A detailed history of Patriot Investment Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Patriot Investment Management Inc. holds 7,277 shares of BMY stock, worth $413,624. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,277
Previous 8,900 18.24%
Holding current value
$413,624
Previous $369,000 1.9%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$39.66 - $51.75 $64,368 - $83,990
-1,623 Reduced 18.24%
7,277 $376,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $109,842 - $144,609
-2,729 Reduced 23.47%
8,900 $369,000
Q1 2024

Apr 16, 2024

SELL
$47.98 - $54.4 $54,697 - $62,016
-1,140 Reduced 8.93%
11,629 $630,000
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $18,519 - $22,098
-382 Reduced 2.9%
12,769 $655,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $91,697 - $102,532
-1,584 Reduced 10.75%
13,151 $763,000
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $84,033 - $93,306
-1,319 Reduced 8.22%
14,735 $942,000
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $102,573 - $116,341
-1,561 Reduced 8.86%
16,054 $1.11 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $220,300 - $260,866
-3,217 Reduced 15.44%
17,615 $1.27 Million
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $284 - $168,049
-2,187 Reduced 9.5%
20,832 $1.48 Million
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $292,731 - $322,399
-4,031 Reduced 14.9%
23,019 $1.77 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $48,261 - $57,870
-785 Reduced 2.82%
27,050 $1.98 Million
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $123,241 - $143,670
2,298 Added 9.0%
27,835 $1.74 Million
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $79,997 - $93,707
1,352 Added 5.59%
25,537 $1.51 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $66,305 - $72,206
1,071 Added 4.63%
24,185 $1.62 Million
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $31,687 - $35,639
534 Added 2.36%
23,114 $1.46 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $12,298 - $13,936
213 Added 0.95%
22,580 $1.4 Million
Q3 2020

Oct 23, 2020

BUY
$57.43 - $63.64 $31,873 - $35,320
555 Added 2.54%
22,367 $1.35 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $69,128 - $80,817
1,261 Added 6.14%
21,812 $1.28 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $151,867 - $220,698
-3,273 Reduced 13.74%
20,551 $1.15 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $43,895 - $57,257
892 Added 3.89%
23,824 $1.53 Million
Q3 2019

Oct 30, 2019

BUY
$42.77 - $50.71 $78,654 - $93,255
1,839 Added 8.72%
22,932 $1.15 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $63,672 - $70,408
1,427 Added 7.26%
21,093 $956,000
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $887,329 - $1.06 Million
19,666 New
19,666 $938,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Patriot Investment Management Inc. Portfolio

Follow Patriot Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patriot Investment Management Inc. with notifications on news.